Specialized Medical Company (4019.SR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Specialized Medical Company, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Valuation | |||||
| P/E Ratio | 17.02x | 122.61x | 134.46x | 220.70x | 405.59x |
| P/B Ratio | 3.80x | 27.46x | 26.84x | 31.05x | 33.17x |
| P/S Ratio | 2.93x | 15.78x | 16.58x | 18.80x | 21.55x |
| Profitability | |||||
| Gross Margin | 24.9% | 26.3% | 25.3% | 22.6% | 21.3% |
| Operating Margin | 15.8% | 16.5% | 15.7% | 10.6% | 6.6% |
| Net Margin | 17.3% | 12.9% | 12.3% | 8.5% | 5.3% |
| EBITDA Margin | 27.1% | 22.7% | 22.7% | 19.9% | 17.2% |
| Liquidity | |||||
| Current Ratio | 1.42x | 0.76x | 0.87x | 0.76x | 1.12x |
| Quick Ratio | 1.37x | 0.70x | 0.83x | 0.73x | 1.08x |
| Leverage | |||||
| Debt/Equity | 0.70x | 1.28x | 1.27x | 1.31x | 1.49x |
YoY = year-over-year change. Source: FMP..